Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q4 EPS of ($0.48), $0.11 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.